Department of neurosurgery, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.
Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.
Neurosurg Rev. 2021 Apr;44(2):721-729. doi: 10.1007/s10143-020-01297-0. Epub 2020 Apr 16.
Whether intermittent pneumatic compression (IPC) is a more effective form of thromboprophylaxis than anticoagulants in individuals undergoing neurosurgery remains controversial. Relevant studies are sparse and inconsistent. Therefore, direct comparisons are difficult to perform and impractical. Hence, we summarized and compared the efficacy and safety of IPC and anticoagulants for the prevention of venous thromboembolism (VTE) in adults undergoing cranial or spinal procedures. Several electronic databases were searched for randomized controlled trials on the use of IPC and anticoagulants for thromboembolism prevention in neurosurgical patients, from inception to August 6, 2019. Studies reporting the selected endpoints were included in direct and Bayesian network meta-analyses to estimate the relative effects of the interventions. Overall, our analysis included 18 trials comprising 2474 patients. Both IPC (RR, 0.41; 95% CrI, 0.26-0.60) and chemical prophylaxis (RR, 0.48; 95% CrI, 0.28-0.68) were found to be more efficacious than the placebo in reducing the risk of deep vein thrombosis (DVT). In addition, our analysis also demonstrated that both IPC (RR, 0.10; 95% CrI, 0.01-0.60) and chemical prophylaxis (RR, 0.31; 95% CrI, 0.05-1.00) reduced the risk of pulmonary embolism (PE) significantly more than the placebo. Based on the available evidence of moderate-to-good quality, IPC is equivalent to anticoagulants for thromboprophylaxis in terms of efficacy. Evidence to support or negate the use of pharmacological prophylaxis in terms of safety is lacking. The results of ongoing and future large randomized clinical trials are needed.
IPC 是否比抗凝剂更能有效预防神经外科患者发生血栓栓塞,这一问题仍存在争议。相关研究较少且结果不一致。因此,直接比较是困难且不切实际的。因此,我们总结并比较了 IPC 和抗凝剂在预防颅脊柱手术成人患者静脉血栓栓塞症(VTE)中的疗效和安全性。从研究开始到 2019 年 8 月 6 日,我们检索了多个电子数据库,以查找关于 IPC 和抗凝剂用于预防神经外科患者血栓栓塞的随机对照试验。纳入了报告所选结局的研究,以进行直接和贝叶斯网络荟萃分析,以估计干预措施的相对效果。总体而言,我们的分析包括了 18 项试验,共纳入 2474 名患者。IPC(RR,0.41;95% CrI,0.26-0.60)和化学预防(RR,0.48;95% CrI,0.28-0.68)均比安慰剂更能有效降低深静脉血栓形成(DVT)的风险。此外,我们的分析还表明,IPC(RR,0.10;95% CrI,0.01-0.60)和化学预防(RR,0.31;95% CrI,0.05-1.00)降低肺栓塞(PE)风险的效果也明显优于安慰剂。基于中高质量证据,IPC 在疗效方面与抗凝剂相当。缺乏支持或否定药物预防在安全性方面的使用的证据。需要正在进行和未来的大型随机临床试验的结果。